80 FR 34693 - Manufacturer of Controlled Substances Registration: Siemens Healthcare Diagnostics, Inc.

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 80, Issue 116 (June 17, 2015)

Page Range34693-34693
FR Document2015-14912

Siemens Healthcare Diagnostics, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Siemens Healthcare Diagnostics, Inc. registration as a manufacturer of those controlled substances.

Federal Register, Volume 80 Issue 116 (Wednesday, June 17, 2015)
[Federal Register Volume 80, Number 116 (Wednesday, June 17, 2015)]
[Notices]
[Page 34693]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-14912]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Siemens 
Healthcare Diagnostics, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Siemens Healthcare Diagnostics, Inc. applied to be registered 
as a manufacturer of certain basic classes of controlled substances. 
The Drug Enforcement Administration (DEA) grants Siemens Healthcare 
Diagnostics, Inc. registration as a manufacturer of those controlled 
substances.

SUPPLEMENTARY INFORMATION: By notice dated January 9, 2015, and 
published in the Federal Register on January 26, 2015, 80 FR 3982, 
Siemens Healthcare Diagnostics, Inc., Attn: RA, 100 GBC Drive, Mailstop 
514, Newark, Delaware 19702 applied to be registered as a manufacturer 
of certain basic classes of controlled substances. No comments or 
objections were submitted to this notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of Siemens Healthcare Diagnostics, 
Inc. to manufacture the basic classes of controlled substances is 
consistent with the public interest and with United States obligations 
under international treaties, conventions, or protocols in effect on 
May 1, 1971. The DEA investigated the company's maintenance of 
effective controls against diversion by inspecting and testing the 
company's physical security systems, verifying the company's compliance 
with state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Ecgonine (9180)............................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
------------------------------------------------------------------------

    The company plans to produce the listed controlled substances in 
bulk to be used in the manufacture of reagents and drug calibrator 
controls which are DEA exempt products.
    In reference to drug code 7370 the company plans to bulk 
manufacture a synthetic tetrahydrocannabinol. No other activity for 
this drug code is authorized for this registration.

    Dated: June 11, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-14912 Filed 6-16-15; 8:45 am]
 BILLING CODE 4410-09-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of registration.
FR Citation80 FR 34693 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR